APA (7th ed.) Citation

O, G., KJ, S., C, B., GM, W., E, B., CE, W., . . . IF, H. (2018). A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: Induction of polyfunctional T cells in high-risk melanoma patients. Cancer immunology, immunotherapy : CII, 67(2), 285. https://doi.org/10.1007/s00262-017-2085-9

Chicago Style (17th ed.) Citation

O, Gasser, et al. "A Phase I Vaccination Study with Dendritic Cells Loaded with NY-ESO-1 and α-galactosylceramide: Induction of Polyfunctional T Cells in High-risk Melanoma Patients." Cancer Immunology, Immunotherapy : CII 67, no. 2 (2018): 285. https://doi.org/10.1007/s00262-017-2085-9.

MLA (9th ed.) Citation

O, Gasser, et al. "A Phase I Vaccination Study with Dendritic Cells Loaded with NY-ESO-1 and α-galactosylceramide: Induction of Polyfunctional T Cells in High-risk Melanoma Patients." Cancer Immunology, Immunotherapy : CII, vol. 67, no. 2, 2018, p. 285, https://doi.org/10.1007/s00262-017-2085-9.